Page last updated: 2024-08-21

taurolithocholic acid and cyclin d1

taurolithocholic acid has been researched along with cyclin d1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amonyingcharoen, S; Satayavivad, J; Suriyo, T; Thiantanawat, A; Watcharasit, P	1

Other Studies

1 other study(ies) available for taurolithocholic acid and cyclin d1

Article	Year
Taurolithocholic acid promotes intrahepatic cholangiocarcinoma cell growth via muscarinic acetylcholine receptor and EGFR/ERK1/2 signaling pathway. International journal of oncology, 2015, Volume: 46, Issue:6 Topics: Bile Acids and Salts; Bile Duct Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Cholangiocarcinoma; Cyclin D1; ErbB Receptors; Humans; MAP Kinase Signaling System; Phosphorylation; Receptors, Muscarinic; Taurolithocholic Acid	2015

Article

Year

Taurolithocholic acid promotes intrahepatic cholangiocarcinoma cell growth via muscarinic acetylcholine receptor and EGFR/ERK1/2 signaling pathway.

International journal of oncology, 2015, Volume: 46, Issue:6

Topics: Bile Acids and Salts; Bile Duct Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Cholangiocarcinoma; Cyclin D1; ErbB Receptors; Humans; MAP Kinase Signaling System; Phosphorylation; Receptors, Muscarinic; Taurolithocholic Acid

2015